Anti-EPHA2 antibody

Details for Australian Patent Application No. 2008292352 (hide)

Owner Daiichi Sankyo Company, Limited

Inventors Ohtsuka, Toshiaki; Urano, Atsushi; Takizawa, Takeshi; Hasegawa, Jun; Nakahara, Kaori; Agatsuma, Toshinori; Yamaguchi, Junko

Agent Davies Collison Cave

Pub. Number AU-B-2008292352

PCT Pub. Number WO2009/028639

Priority 2007-224007 30.08.07 JP

Filing date 29 August 2008

Wipo publication date 5 March 2009

Acceptance publication date 8 March 2012

International Classifications

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/028639 Priority application(s): WO2009/028639

8 March 2012 Application Accepted

  Published as AU-B-2008292352

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008292356-Method for production of carotenoid

2008292349-Ferric arsenate powder